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INTRODUCTION
The morbidity and mortality rates after acute ischemic stroke
from internal carotid artery (ICA) occlusion are high (1, 2). Only
18-26% of patients with acute ICA occlusion who received intrave-
nous (iv) recombinant tissue-type plasminogen activator (rt -PA)
therapy alone showed early recanalization (3-6).
The addition of endovascular - to iv rt -PA therapy was suggested
to be effective in patients with acute ICA occlusion (7-9). However,
when carotid artery stenting (CAS) is the salvage method in pa-
tients with cervical ICA stenosis who had undergone iv rt -PA treat-
ment, antithrombotic- including antiplatelet agents are required
during and after CAS to prevent stent thrombosis. The administra-
tion of such agents within 24 hours after rt -PA may increase the
risk for major bleeding, in particular of intracerebral hemorrhage.
There are few reports of emergent carotid endarterectomy
(CEA) within 24 hours after rt -PA treatment in patients with acute
ICA occlusion. We report a patient who underwent emergent CEA
after iv rt -PA treatment and whose outcome was good.
CASE REPORT
A 58-year-old man was referred to our emergency room 90
minutes after the sudden onset of left hemiplegia and dysarthria
during the consumption of alcohol. His lifestyle included smoking
and drinking and he had a history of hypertension, diabetes melli-
tus, and dyslipidemia. At the time of his admission he was confused
(Glasgow Coma Scale ; E4V4M6) ; neurological findings were con-
sciousness disturbance, conjugate deviation to the right, dysarthria,
left facial palsy, and left severe hemiparesis (manual muscle test-
ing : upper 1/5 lower 3/5). His initial National Institute of Health
Stroke Scale (NIHSS) score was 14. Neither an abnormal cardiac
rhythm nor congestiveheart failure was noted. Diffusion-weighted
imaging (DWI) showed multiple high- intensity lesions in the right
frontal lobe and insular cortex (Figure 1A). Magnetic resonance
angiography (MRA) revealed occlusion of the cervical portion of
the right ICA, there was faint flow in the right middle- and anterior
cerebral arteries via the anterior - and posterior communicating
artery providing collateral circulation (Figure 1B). Echo lucency
was low on ultrasound images of a carotid atherosclerotic plaque.
He was treated with iv rt -PA (0.6 mg/kg) 3 hours post-onset.
MRA images obtained immediately after the iv administration
of rt -PA demonstrated no recanalization of the right ICA. On DWI
scans an ischemic region was clearly visualized ; the area had not
expanded (Figure 2). The conjugate deviation to the right disap-
peared, his level of consciousness improved, and his NIHSS score
was 9. As it was unclear whether MRA indicated complete- or
pseudo-occlusion of the ICA we performed cerebral angiography
to determine his hemodynamic status. Based on North American
Symptomatic Carotid Endarterectomy Trial (NASCET) criteria it
showed 95% stenosis of the proximal ICA ; the blood flow was an-
terograde and slow (Figure 3) without supplementary flow from
other arteries. He subsequently developed unstable neurological
deficits and his NIHSS score fluctuated between 7 and 11. To pre-
vent stroke progression we decided to perform CEA 10.5 hours
after the administration of iv rt -PA. Coronary angiography did not
identify coronary artery disease and we considered him able to tol-
erate general anesthesia.
Under general anesthesia he underwent CEA with intraopera-
tive shunting because the blood flow was anterograde and faint.
The procedure was uneventful and there were no bleeding compli-
cations. The atherosclerotic soft plaque harboring cholesterol was
fragile and led to thrombus formation.
He was kept under continuous sedation with dexmedetomidine
for 4 days after CEA to avoid intracerebral hemorrhage related to
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Figure 1
Imaging studies performed at the time of admission.
A.Diffusion-weighted image (DWI) showing multiple high- intensity lesions in the right frontal lobe and insular cortex.
B. Magnetic resonance angiography (MRA) showing occlusion of the cervical portion of the right internal carotid artery (ICA) and faint flow in the
right middle -and anterior cerebral arteries via the anterior - and posterior communicating artery providing collateral circulation.
Figure 2
Imaging studies performed after the iv administration of recombinant tissue- type plasminogen activator (rt -PA).
A. DWI showing multiple high- intensity lesions in the right frontal lobe and insular cortex. The ischemic region is clearly depicted. Comparison
with the image acquired at the time of admission showed no expansion of the region.
B. After the administration of rt -PA, no recanalization of the right ICA was observed.
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hyperperfusion syndrome and his blood pressure was strictly con-
trolled. In addition, we administered the free radical scavenger eda-
ravone for two weeks. Postoperatively his left severe hemiparesis
improved slowly ; his NIHSS score was 5. MRA performed one day
post-CEA revealed that his ICA was free of stenosis ; DWI revealed
no new ischemic lesions (Figure 4). Computed tomography per-
formed 3 and 10 days post-CEA showed no intracerebral hemor-
rhage. One month post-CEA he could walk with a stick and was
discharged. His modified Rankin scale (mRS) score 3 months after
CEA was 3.
Figure 3
Digital subtraction angiogram showing 95% stenosis of the proximal ICA. Although recanalization of the right ICA occlusion was obtained, the blood
flow was very slow and anterograde without supplementary flow from other arteries.
Figure 4
Postoperative imaging studies
A. DWI showing multiple high- intensity lesions in the right frontal lobe and insular cortex, but no new ischemic lesions. Comparison with the image
acquired at the time of admission showed no expansion of the ischemic area.
B. MRA showing the ICA free of stenosis. The intracranial ICA and the middle cerebral artery are clearly depicted.
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DISCUSSION
We reported a patient with acute ICA occlusion who underwent
CEA 10.5 hours after the administration of iv rt -PA. We paid careful
attention to stop intraoperative bleeding, we controlled his postop-
erative blood pressure under sedation, and administered edaravone
to prevent hyperperfusion. There were no hemorrhagic compli-
cations.
In patients with acute ICA occlusion it is difficult to obtain reca-
nalization after the administration of iv rt -PA alone (3-6). Even
after recanalization severe extracranial ICA stenosis may persist,
increasing the risk for progressive stroke or ICA reocclusion in the
acute phase. Salvage methods for severe residual stenosis at the
origin of the ICA include CAS and CEA.
CAS can be performed non- invasively and immediately after
evaluation of the cerebral hemodynamic status on cerebral angi-
ographs. It may help to address a critical stenosis resulting in a
reduction in the cerebral blood flow in the affected hemisphere
during the intervention. Some patients who underwent emergent
CAS after rt -PA have been reported (10-12) ; however, this proce-
dure requires the administration of anticoagulants during and after
the operation and may elicit hemorrhagic complications. Accord-
ing to Kimura et al. (13), recanalization between 1 and 24 hours
after rt -PA therapy was a strong predictor of intracerebral hemor-
rhage. Consequently, they argued against the administration of
antithrombotic agents. Villwock et al. (14) reported that CAS plus
the administration of rt -PA increased the odds for complications
and death. In addition, in the presence of vulnerable carotid plaques
or tortuous carotid lesions, and when it is difficult to access the ICA,
CAS may not be appropriate.
On the other hand, some patients underwent early CEA after
thrombolysis (12, 15-17). Yong et al. (15) who assessed the safety
of CEA performed 0-54 days after thrombolysis for acute ischemic
stroke found that the incidence of intracerebral hemorrhage within
the first 30 days was 3%. They suggested that CEA after thromboly-
sis would be safe.
Patients who undergo emergency CEA within 24 hours after rt -
PA are at high risk for intracerebral hemorrhage and only 3 such
patients have been reported (18-20). They underwent the proce-
dure 4.2-, 2 -, and 6 hours after the iv administration of rt -PA for ICA
pseudo-occlusion or occlusion of the common carotid artery and
the ICA. Their NIHSS score before CEA was 22, 19, and 5 and none
suffered peri -operative hemorrhagic complications. These reports
indicate that careful patient selection and post-CEA management
are extremely important. Patients with mild neurological deficits,
without significant ischemic areas, and those with good collateral
flow may be candidates for emergency CEA after rt -PA. Although
our patient manifested unstable neurological deficits, angiog-
raphs acquired immediately after the administration of iv rt -PA
showed good collateral flow that may have contributed to his good
outcome.
To avoid post-CEA intracerebral hemorrhage, we administered
edaravone and paid special attention to avoid postoperative hyper-
tension. According to Yagi et al. (21), while rt -PA induced the up-
regulation of matrix metalloproteinase-9 (MMP-9) and elicited
intracerebral hemorrhage in rats subjected to 3-hour middle cere-
bral artery occlusion, edaravone inhibited rt -PA-induced cerebral
hemorrhage by inhibiting the expression of MMP-9. In our patient,
edaravone plus strict blood pressure control under sedation ap-
pears to have prevented post-CEA intracerebral hemorrhage.
Pharmacokinetically, iv rt -PA is very short acting ; its serum
half - life is only about 5 minutes and Cmax is reached 55 minutes
after the start of its administration. At 90 minutes the blood level
decreases to 10% of Cmax, and at 4 hours it is 1% of Cmax (18, 20). We
posit that at 10.5 hours the effects of iv rt -PA had worn off suffi-
ciently to render CEA safe in our patient. However, plasma markers
to confirm this hypothesis have not been established yet and, fur-
ther study is needed.
To prevent perioperative complications, in most cases CEA
should not be performed less than 24 hours after thrombolysis.
However, when the patient is neurologically unstable and the insti-
tution has enough experience with CEA, it may be considered as
an optional treatment. In our patient, emergency CEA for residual
severe ICA stenosis after iv rt -PA treatment resulted in the im-
provement of his neurological signs and there were no complica-
tions. As this report presents our experience with a single patient,
further investigations are needed to determine the safety and
efficacy of emergency CEA after iv rt -PA treatment and to identify
patients who are candidates for emergency CEA.
CONCLUSION
We reported a patient with acute ICA occlusion who underwent
successful CEA 10.5 hours after the administration of iv rt -PA.
Emergency CEA may be an option to address post- treatment se-
vere residual ICA stenosis. Additional studies are needed to confirm
the safety and efficacy of emergency CEA.
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